These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 17546696)
1. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003. Van Dyke DL; Ebrahim SA; Al Saadi AA; Powell SA; Zenger-Hain JL; Micale MA; Wiktor AE; Zou YS Prenat Diagn; 2007 Jun; 27(6):583-4. PubMed ID: 17546696 [No Abstract] [Full Text] [Related]
2. Congenital deficiency of AFP and Down syndrome screening. Sher C; Shohat M Prenat Diagn; 1997 Sep; 17(9):884-5. PubMed ID: 9316138 [No Abstract] [Full Text] [Related]
3. Multiple marker screening. Dickerson VM West J Med; 1994 Aug; 161(2):161. PubMed ID: 7524245 [No Abstract] [Full Text] [Related]
4. 46,XY,i(21q) identified by maternal serum screening. Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908 [TBL] [Abstract][Full Text] [Related]
5. Current techniques of prenatal screening for Down syndrome. Cardwell MS; Gay JW Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954 [TBL] [Abstract][Full Text] [Related]
6. Maternal alpha-fetoprotein screening for Down's syndrome. Pueschel SM N Engl J Med; 1987 Aug; 317(6):376-8. PubMed ID: 2439910 [No Abstract] [Full Text] [Related]
7. Cautions about maternal serum alpha-fetoprotein screening. Milunsky A; Haddow JE N Engl J Med; 1985 Sep; 313(11):694. PubMed ID: 2410789 [No Abstract] [Full Text] [Related]
9. Serum hyperglycosylated hCG: a potential screening test for fetal Down syndrome. Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ; Omrani A; Baumgarten A; Cole LA Prenat Diagn; 1999 May; 19(5):488-9. PubMed ID: 10360522 [No Abstract] [Full Text] [Related]
10. [Antenatal screening for Down syndrome: a smattering of epidemiology]. Boulvain M; Billieux MH; Irion O Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of decreased serum levels of AFP in the detection of fetal trisomy in screening examinations of pregnant women]. Lippert P; Ulbrichová Z; Benesová O Cesk Gynekol; 1989 Jul; 54(6):430-6. PubMed ID: 2477161 [No Abstract] [Full Text] [Related]
13. [Multiple of the median and its uses in antenatal screening]. Jiangsu Province Birth Planning Commitee Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334 [No Abstract] [Full Text] [Related]
14. [Prenatal screening for Down syndrome: from sequential to combined estimated risk]. Jouannic JM; Benifla JL Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636 [No Abstract] [Full Text] [Related]
15. Second-trimester maternal serum screening for Down syndrome in Mainland China. Liao C; Huang Y; Li D; Song S; Yi C; Zhou J Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699 [No Abstract] [Full Text] [Related]
16. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province]. Hu YL; Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809 [TBL] [Abstract][Full Text] [Related]
17. [Screening for alpha-1-fetoprotein in maternal serum. Clinical and organizational aspects in the Central Bohemia Region]. Stejskal D; Malbohan I Cesk Gynekol; 1988 Aug; 53(7):538-43. PubMed ID: 2458848 [No Abstract] [Full Text] [Related]
18. Maternal serum screening for neural tube defects and Down syndrome. Keith D Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964 [No Abstract] [Full Text] [Related]
19. Testing for Down syndrome in the older woman: a risky business? Hodges RJ; Wallace EM Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):486-8. PubMed ID: 16401213 [TBL] [Abstract][Full Text] [Related]
20. Maternal serum alpha-fetoprotein screening and Down's syndrome. Wu LR Am J Obstet Gynecol; 1986 Dec; 155(6):1362-3. PubMed ID: 2431621 [No Abstract] [Full Text] [Related] [Next] [New Search]